• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体介导的免疫沉淀抑制作用。I. 经典途径和替代途径的作用

Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

作者信息

Schifferli J A, Woo P, Peters D K

出版信息

Clin Exp Immunol. 1982 Mar;47(3):555-62.

PMID:6979442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1536444/
Abstract

This study has examined the mechanisms involved in complement-mediated inhibition of immune precipitation using radiolabelled BSA and rabbit anti-BSA. Purified proenzyme C1 was capable of maintaining the complexes in soluble form during the first few minutes of reaction whereas immune precipitation was immediate in the presence of purified C1q or C1 + EDTA (ethylenediamine tetra-acetate). In C1q deficient serum, initial immune aggregation was followed by partial solubilization of the formed precipitate similar to that obtained with normal human serum in the presence of Mg EGTA. In C2 deficient serum precipitation occurred at a slow rate. Repletion of the deficient component (C1q or C2 respectively) restored fully inhibition of precipitation. These experiments establish a critical role for the classical pathway, in this phenomenon. By contrast the role of the alternative pathway in maintaining complexes in solution was less important; only partial and delayed precipitation occurred in sera depleted of factor D (RD) or factor B (RB). B and D restored normal complement activity to depleted sera. No precipitation was detected in a reagent depleted of properdin (RP). The mechanisms of inhibition of precipitation are therefore distinct from those responsible for solubilization of an immune precipitate, which is largely dependent on the alternative pathway.

摘要

本研究使用放射性标记的牛血清白蛋白(BSA)和兔抗牛血清白蛋白,研究了补体介导的免疫沉淀抑制机制。纯化的酶原C1能够在反应的最初几分钟内使复合物保持可溶形式,而在纯化的C1q或C1 + 乙二胺四乙酸(EDTA)存在下,免疫沉淀立即发生。在C1q缺陷血清中,最初的免疫聚集之后是形成的沉淀物部分溶解,类似于在存在Mg EGTA的正常人血清中获得的情况。在C2缺陷血清中,沉淀以缓慢的速率发生。补充缺陷成分(分别为C1q或C2)可完全恢复对沉淀的抑制。这些实验确立了经典途径在这一现象中的关键作用。相比之下,替代途径在维持复合物处于溶液中的作用不太重要;在缺乏因子D(RD)或因子B(RB)的血清中仅发生部分和延迟的沉淀。B和D使耗尽的血清恢复正常补体活性。在缺乏备解素(RP)的试剂中未检测到沉淀。因此,沉淀抑制机制与负责免疫沉淀物溶解的机制不同,后者很大程度上依赖于替代途径。

相似文献

1
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.补体介导的免疫沉淀抑制作用。I. 经典途径和替代途径的作用
Clin Exp Immunol. 1982 Mar;47(3):555-62.
2
Prevention of immune precipitation by purified classical pathway complement components.利用纯化的经典途径补体成分预防免疫沉淀。
Clin Exp Immunol. 1984 Nov;58(2):486-92.
3
Prevention of immune precipitation by purified components of the alternative pathway.通过替代途径的纯化成分预防免疫沉淀。
Clin Exp Immunol. 1985 Apr;60(1):169-77.
4
Inhibition of immune precipitation by complement.补体对免疫沉淀的抑制作用。
Clin Exp Immunol. 1980 Nov;42(2):387-94.
5
Inhibition of immune precipitation by complement.补体对免疫沉淀的抑制作用。
J Immunol. 1984 Sep;133(3):1464-70.
6
The role of C1, C1-inactivator and C4 in modulating immune precipitation.C1、C1灭活剂和C4在调节免疫沉淀中的作用。
Clin Exp Immunol. 1985 Jun;60(3):605-12.
7
Control of immune complexes by the classical pathway.经典途径对免疫复合物的调控
Behring Inst Mitt. 1989 Jul(84):111-20.
8
The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.经典途径成分在替代途径调节的免疫复合物聚集中的作用:C1抑制物的作用。
Behring Inst Mitt. 1984 Nov(76):29-41.
9
Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.补体激活以及在原发性混合性冷球蛋白血症中溶解免疫复合物或阻止其形成的能力受损。
Diagn Immunol. 1983;1(4):315-23.
10
The modulation of immune complex aggregation by classical pathway-mediated reactions.经典途径介导的反应对免疫复合物聚集的调节作用。
Immunobiology. 1985 May;169(4):346-61. doi: 10.1016/S0171-2985(85)80016-4.

引用本文的文献

1
The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?补体在乙酰胆碱受体抗体阳性全身型重症肌无力免疫发病机制中的作用:旁观者还是关键参与者?
Front Immunol. 2025 Apr 15;16:1526317. doi: 10.3389/fimmu.2025.1526317. eCollection 2025.
2
The Contribution of Complement Protein C1q in COVID-19 and HIV Infection Comorbid with Preeclampsia: A Review.补体蛋白 C1q 在 COVID-19 和 HIV 感染合并子痫前期中的作用:综述。
Int Arch Allergy Immunol. 2022;183(10):1114-1126. doi: 10.1159/000524976. Epub 2022 Jun 3.
3
Reproductive immunology in viviparous mammals: evolutionary paradox of interactions among immune mechanisms and autologous or allogeneic gametes and semiallogeneic foetuses.胎生哺乳动物的生殖免疫学:免疫机制与自体或同种异体配子及半同种异体胎儿之间相互作用的进化悖论
Vet Q. 2020 Dec;40(1):353-383. doi: 10.1080/01652176.2020.1852336.
4
Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.溶组织内阿米巴半乳糖/ N - 乙酰半乳糖胺凝集素中间亚基C末端片段作为抗阿米巴肝脓肿疫苗候选物的评估
PLoS Negl Trop Dis. 2016 Jan 29;10(1):e0004419. doi: 10.1371/journal.pntd.0004419. eCollection 2016 Jan.
5
Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.用溶组织内阿米巴表面金属蛋白酶EhMSP-1进行免疫可保护仓鼠免受阿米巴肝脓肿的侵害。
Infect Immun. 2015 Feb;83(2):713-20. doi: 10.1128/IAI.02490-14. Epub 2014 Dec 1.
6
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.MRL/lpr小鼠中C4及C4结合蛋白的分析
Arthritis Res Ther. 2007;9(5):R114. doi: 10.1186/ar2320.
7
The plasma protein which inhibits complement-mediated prevention of immune precipitation is an Fc binding protein.抑制补体介导的免疫沉淀阻止作用的血浆蛋白是一种Fc结合蛋白。
Immunology. 1989 Jan;66(1):20-5.
8
Immune complex-FcgammaR interaction modulates monocyte/macrophage molecules involved in inflammation and immune response.免疫复合物与Fcγ受体的相互作用调节参与炎症和免疫反应的单核细胞/巨噬细胞分子。
Clin Exp Immunol. 2003 Aug;133(2):200-7. doi: 10.1046/j.1365-2249.2003.02208.x.
9
Recombinant soluble Fc gamma RII inhibits immune complex precipitation.重组可溶性FcγRII抑制免疫复合物沉淀。
Clin Exp Immunol. 1995 Dec;102(3):620-5. doi: 10.1111/j.1365-2249.1995.tb03862.x.
10
The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).抗脂质A抗体HA-1A与粗糙型革兰氏阴性菌结合,固定补体并促进与红细胞CR1(CD35)的结合。
Clin Exp Immunol. 1993 May;92(2):232-8. doi: 10.1111/j.1365-2249.1993.tb03385.x.

本文引用的文献

1
The properdin system and immunity. IX. Studies on the purification of human properdin.备解素系统与免疫。IX. 关于人备解素纯化的研究。
J Immunol. 1959 Oct;83:418-27.
2
Inhibition of immune precipitation by complement.补体对免疫沉淀的抑制作用。
Clin Exp Immunol. 1980 Nov;42(2):387-94.
3
A genetic defect of the C1q subcomponent of complement associated with childhood (immune complex) nephritis.一种与儿童期(免疫复合物)肾炎相关的补体C1q亚成分的基因缺陷。
N Engl J Med. 1980 Jul 3;303(1):22-4. doi: 10.1056/NEJM198007033030107.
4
Antigen valence and Fc-localized secondary forces in antibody precipitation.抗体沉淀中的抗原价与Fc定位的二级作用力
Mol Immunol. 1980 Dec;17(12):1591-7. doi: 10.1016/0161-5890(80)90185-6.
5
Molecular biology and chemistry of the alternative pathway of complement.补体替代途径的分子生物学与化学
Adv Immunol. 1980;29:1-53. doi: 10.1016/s0065-2776(08)60042-5.
6
The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.通过胃蛋白酶消化抗原-抗体沉淀物将特异性抗体纯化为F(ab')2及其在免疫球蛋白和补体抗原中的应用。
Immunochemistry. 1971 Jan;8(1):81-8. doi: 10.1016/0019-2791(71)90423-x.
7
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.补体C1q成分在凝胶扩散中与聚集的γ-球蛋白及免疫复合物的沉淀素反应。
Immunology. 1970 Dec;19(6):909-19.
8
Studies on the mechanism of solubilization of immune precipitates by serum.血清溶解免疫沉淀物的机制研究。
J Exp Med. 1976 Mar 1;143(3):615-30. doi: 10.1084/jem.143.3.615.
9
A new complement function: solubilization of antigen-antibody aggregates.一种新的补体功能:抗原-抗体聚集体的溶解
Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22. doi: 10.1073/pnas.72.2.418.
10
The unactivated form of the first component of human complement, C1.人类补体第一成分C1的未活化形式。
Biochem J. 1976 Sep 1;157(3):541-8. doi: 10.1042/bj1570541.